oxycodone and Contact Dermatitis

oxycodone has been researched along with Contact Dermatitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bryniarski, K; Filipczak-Bryniarska, I; Kozlowski, M; Nazimek, K; Nowak, B; Wąsik, M	1

Other Studies

1 other study(ies) available for oxycodone and Contact Dermatitis

Article	Year
In contrast to morphine, buprenorphine enhances macrophage-induced humoral immunity and, as oxycodone, slightly suppresses the effector phase of cell-mediated immune response in mice. International immunopharmacology, 2018, Volume: 54 Topics: Animals; Buprenorphine; Cells, Cultured; Cytokines; Dermatitis, Contact; Homeostasis; Humans; Immunity, Cellular; Immunity, Humoral; Immunomodulation; Macrophages; Male; Mice; Mice, Inbred CBA; Morphine; Nitric Oxide; Oxycodone; Reactive Oxygen Species	2018

Article

Year

In contrast to morphine, buprenorphine enhances macrophage-induced humoral immunity and, as oxycodone, slightly suppresses the effector phase of cell-mediated immune response in mice.

International immunopharmacology, 2018, Volume: 54

Topics: Animals; Buprenorphine; Cells, Cultured; Cytokines; Dermatitis, Contact; Homeostasis; Humans; Immunity, Cellular; Immunity, Humoral; Immunomodulation; Macrophages; Male; Mice; Mice, Inbred CBA; Morphine; Nitric Oxide; Oxycodone; Reactive Oxygen Species

2018